Laparoscopic sleeve gastrectomy for morbid obesity: 5-year results - 13/02/15
, Antonios Athanasiou, M.D., Adamantios Michalinos, M.D., Evangelos Felekouras, M.D., Ph.D., Christos Tsigris, M.D., Ph.D, Theodoros Diamantis, M.D., Ph.D.Abstract |
Background |
Data concerning the long-term efficacy of laparoscopic sleeve gastrectomy in the treatment of morbid obesity remain scarce. In this retrospective, the authors present 5-year follow-up of 30 patients having undergone laparoscopic sleeve gastrectomy.
Methods |
Since 2004, 30 patients underwent laparoscopic sleeve gastrectomy and completed 5 years of follow-up. Five patients were subsequently subjected to laparoscopic Roux-en-Y gastric bypass and were excluded from further analysis. The remaining 25 patients comprised the study population.
Results |
Mean excess weight loss was 65.2 ± 6.1%, 64.7 ± 5.6%, 62 ± 4.9%, 58.2 ± 5.5%, and 56.4 ± 5.8% for the first 5 years, respectively. There were no deaths, nor any major morbidity. Remission of comorbidities was observed in 40% to 80.9% of cases.
Conclusions |
Laparoscopic sleeve gastrectomy is a safe and effective means of treatment of morbid obesity both in the short and in the long term. More research is needed to better predict which patient will benefit most from this operation.
Le texte complet de cet article est disponible en PDF.Keywords : Sleeve gastrectomy, Morbid obesity, Excess weight loss, 5-Year results
Plan
| The authors declare no conflicts of interest. |
Vol 209 - N° 2
P. 230-234 - février 2015 Retour au numéro
Article précédent
- Patient-specific risk factors are predictive for postoperative adverse events in colorectal surgery: an American College of Surgeons National Surgical Quality Improvement Program–based analysis
- Adrian Y. Kohut, James J. Liu, David E. Stein, Richard Sensenig, Juan L. Poggio
- Percutaneous embolization of thoracic duct injury post-esophagectomy should be considered initial treatment for chylothorax before proceeding with open re-exploration
- Kyle J. Marthaller, Stephen P. Johnson, Robert M. Pride, Erick R. Ratzer, Harris W. Hollis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?